Quantum diffusion on a cyclic one dimensional lattice

The quantum diffusion of a particle in an initially localized state on a cyclic lattice with N sites is studied. Diffusion and reconstruction time are calculated. Strong differences are found for even or odd number of sites and the limit N->infinit is studied. The predictions of the model could be tested with micro - and nanotechnology devices.Comment: 17 pages, 5 figure

Lymphangioleiomyomatosis: What do we know and what are we looking for?

Lymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects predominantly females and can occur sporadically or in patients with tuberous sclerosis complex. This review describes the recent progress in our understanding of the molecular pathogenesis of the disease and LAM cell biology. It also summarises current therapeutic approaches and the most promising areas of research for future therapeutic strategies

Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis)

Generalised lymphatic anomaly (GLA), also known as lymphangiomatosis, is a rare disease caused by congenital abnormalities of lymphatic development. It usually presents in childhood but can also be diagnosed in adults. GLA encompasses a wide spectrum of clinical manifestations ranging from singleorgan involvement to generalised disease. Given the rarity of the disease, most of the information regarding it comes from case reports. To date, no clinical trials concerning treatment are available. This review focuses on thoracic GLA and summarises possible diagnostic and therapeutic approaches

New insights in lymphangioleiomyomatosis and pulmonary langerhans cell histiocytosis

Lymphangioleiomyomatosis (LAM) and pulmonary Langerhans cell histiocytosis (PLCH) are rare diseases that lead to progressive cystic destruction of the lungs. Despite their distinctive characteristics, these diseases share several features. Patients affected by LAM or PLCH have similar radiological cystic patterns, a similar age of onset, and the possibility of extrapulmonary involvement. In this review, the recent advances in the understanding of the molecular pathogenesis, as well as the current and most promising biomarkers and therapeutic approaches, are described

Severe idiopathic pulmonary fibrosis: What can be done?

Idiopathic pulmonary fibrosis (IPF) remains a challenging disease to manage. Two drugs are now available that can slow disease progression in patients with mild-to-moderate IPF. This means that early diagnosis is mandatory, because there are no proven effective therapies for severe IPF. This lack of proven therapies may be at least partially due to the fact that severe IPF patients are usually not enrolled in randomised, prospective, multicentre, international trials. Clinical observation experiences and preliminary results of long-term, open-label extensions of clinical trials suggest that both pirfenidone and nintedanib may also slow or decrease progression in patients with severe IPF. However, data are sparse and obtained from a relatively small number of patients. Lung transplantation should be taken into account early and discussed with patients, when indicated. Rehabilitative strategies are important and effective supportive therapies. The needs of patients with severe IPF are similar to those of patients with an advanced neoplastic disease. Palliative care and psychological support play an important role in the relief of symptoms of anxiety and depression. Accordingly, these therapeutic approaches should start early in IPF patients

Feasibility and interpretation of FENO measurements in asthma patients in general practice

n/

On the Coherent State Path Integral for Linear Systems

We present a computation of the coherent state path integral for a generic linear system using ``functional methods'' (as opposed to discrete time approaches). The Gaussian phase space path integral is formally given by a determinant built from a first-order differential operator with coherent state boundary conditions. We show how this determinant can be expressed in terms of the symplectic transformation generated by the (in general, time-dependent) quadratic Hamiltonian for the system. We briefly discuss the conditions under which the coherent state path integral for a linear system actually exists. A necessary -- but not sufficient -- condition for existence of the path integral is that the symplectic transformation generated by the Hamiltonian is (unitarily) implementable on the Fock space for the system.Comment: 15 pages, plain Te

New results on pushdown module checking with imperfect information

Model checking of open pushdown systems (OPD) w.r.t. standard branching temporal logics (pushdown module checking or PMC) has been recently investigated in the literature, both in the context of environments with perfect and imperfect information about the system (in the last case, the environment has only a partial view of the system's control states and stack content). For standard CTL, PMC with imperfect information is known to be undecidable. If the stack content is assumed to be visible, then the problem is decidable and 2EXPTIME-complete (matching the complexity of PMC with perfect information against CTL). The decidability status of PMC with imperfect information against CTL restricted to the case where the depth of the stack content is visible is open. In this paper, we show that with this restriction, PMC with imperfect information against CTL remains undecidable. On the other hand, we individuate an interesting subclass of OPDS with visible stack content depth such that PMC with imperfect information against the existential fragment of CTL is decidable and in 2EXPTIME. Moreover, we show that the program complexity of PMC with imperfect information and visible stack content against CTL is 2EXPTIME-complete (hence, exponentially harder than the program complexity of PMC with perfect information, which is known to be EXPTIME-complete).Comment: In Proceedings GandALF 2011, arXiv:1106.081

Go Vegan

La méthode de mesure, due à Vernotte, des caractéristiques thermophysiques d'une plaque d'un matériau donné par application d'un film chauffant sur une face de la plaque et enregistrement en fonction du temps de l'évolution des températures de la face opposée, et éventuellement de la face chauffée, a été souvent mise en application. On précise ici quelles conditions doivent être remplies et quelles sont les incidences de divers défauts éventuels du montage quand on applique la variante due à Krischer de cette méthode. Un dispositif expérimental très simple a permis de corroborer ces considérations théoriques